SUVRETTA CAPITAL MANAGEMENT, LLC - BENITEC BIOPHARMA INC ownership

BENITEC BIOPHARMA INC's ticker is BNTC and the CUSIP is 08205P100. A total of 18 filers reported holding BENITEC BIOPHARMA INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
SUVRETTA CAPITAL MANAGEMENT, LLC ownership history of BENITEC BIOPHARMA INC
ValueSharesWeighting
Q2 2023$3,117,911
+1831.6%
769,0000.0%0.17%
+2285.7%
Q1 2023$161,413
+23.5%
769,0000.0%0.01%
+40.0%
Q4 2022$130,730
-54.3%
769,0000.0%0.01%
-58.3%
Q3 2022$286,000
-67.9%
769,0000.0%0.01%
-64.7%
Q2 2022$892,000
-50.3%
769,0000.0%0.03%
-38.2%
Q1 2022$1,796,000
-10.9%
769,0000.0%0.06%
+41.0%
Q4 2021$2,015,000
-26.6%
769,0000.0%0.04%
-15.2%
Q3 2021$2,745,000
-16.0%
769,0000.0%0.05%
-6.1%
Q2 2021$3,268,000769,0000.05%
Other shareholders
BENITEC BIOPHARMA INC shareholders Q2 2023
NameSharesValueWeighting ↓
SUVRETTA CAPITAL MANAGEMENT, LLC 769,000$130,7300.01%
Virtu Financial LLC 80,867$140.00%
FRANKLIN RESOURCES INC 10,000,000$1,700,0000.00%
Walleye Capital LLC 344,015$58,4830.00%
WealthTrust Axiom LLC 12,950$2,2020.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
UBS Group AG 1,274$2170.00%
Rockefeller Capital Management L.P. 300$00.00%
TWO SIGMA INVESTMENTS, LP 28,953$4,9220.00%
Rosenberg Matthew Hamilton 381$650.00%
View complete list of BENITEC BIOPHARMA INC shareholders